Antengene is committed to providing novel therapeutics to patients in Asia Pacific. We offer value-added partnership via leading complementary development in Asia while contributing to existing global development plans of our partners. We are also a regional partner for optimal commercialization with:
•  Tailored local market access strategy
•  Customized commercialization implementation and operations
•  On-the-ground field force and Medical Affairs team
•  Efficient local distributors and supply chain logistics

We welcome discussions on strategic and creative collaborations in assets including:
•  IND-ready programs
•  Post clinical PoC programs
•  Cellular therapies
•  Commercial-stage products

Therapeutic areas of our specialization and interests include but not limited to:
•  Oncology
•  Auto-immune
•  Anti-infection
•  Diseases with higher prevalence/incidence among Asian population

For more information on partnership opportunities with Antengene Corporation,